ACEI and ARB use in CKD has been available for over three decades, but it is still underutilized. Now, a new clinical ...

Initiation of ACEi or ARB therapy reduces the risk for kidney failure, but does not appear to prolong overall survival in patients with advanced CKD. In patients with advanced chronic kidney disease ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Anaheim, CA - First calcium channel blockers (CCBs), now -blockers: both have now been edged out by ACE inhibitors as a means of slowing progression of renal disease in African Americans with ...